Captopril: Difference between revisions
Elcatracho (talk | contribs) |
|||
| Line 33: | Line 33: | ||
*Metabolism: Hepatic | *Metabolism: Hepatic | ||
*Excretion: Renal, dialzable | *Excretion: Renal, dialzable | ||
*Rapid onset | |||
==Mechanism of Action== | ==Mechanism of Action== | ||
Latest revision as of 05:39, 20 August 2022
Administration
- Type: ACE inhibitor
- Dosage Forms: tablet
- Dosage Strengths: 12.5, 25, 50, 100mg
- Routes of Administration: PO
- Common Trade Names: Capoten, Captoril
Adult Dosing
- 6.25-150mg PO three times per day
Pediatric Dosing
Safety/efficacy not established in pediatric patients
Special Populations
- Pregnancy Rating: D
- Lactation risk: Infant risk minimal
- Renal dosing: Initial dose should be reduced, titrate in smaller increments
Contraindications
- Allergy to class/drug
- History of ACE-inhibitor induced angioedema
Adverse Reactions
Serious
- Angioedema
- Stevens-Johnson syndrome
- Agranulocytosis, neutropenia
Common
- Hypotension
- Hyperkalemia
- Cough
- Rash
Pharmacology
- Half-life: < 3 hours
- Metabolism: Hepatic
- Excretion: Renal, dialzable
- Rapid onset
Mechanism of Action
- Inhibits angiotensin I-converting enzyme, blocks conversion of angiotensin I→ angiotensin II